Authors: FENNESSY PA GODWIN S HEAD GA CAMPBELL JH CAMPBELL GR

Citation: Pa. Fennessy et al., SHORT-TERM AND LONG-TERM CARDIOVASCULAR ACTIONS OF DIFFERENT DOSES OFPERINDOPRIL IN THE RABBIT, Pharmacological research, 34(3-4), 1996, pp. 135-141

Authors: FENNESSY PA CAMPBELL JH MENDELSOHN FAO CAMPBELL GR

Citation: Pa. Fennessy et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS AND ATHEROSCLEROSIS - RELEVANCE OF ANIMAL-MODELS TO HUMAN-DISEASE, Clinical and experimental pharmacology and physiology, 23(8), 1996, pp. 30-32

Authors: FENNESSY PA CAMPBELL JH CAMPBELL GR

Citation: Pa. Fennessy et al., AN ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, PERINDOPRIL, PREVENTS PROGRESSION OF PREFORMED ATHEROSCLEROTIC LESIONS IN THE CHOLESTEROL-FED RABBIT, Clinical science, 87(6), 1994, pp. 685-691

Authors: FENNESSY PA CAMPBELL JH CAMPBELL GR

Citation: Pa. Fennessy et al., PERINDOPRIL INHIBITS BOTH THE DEVELOPMENT OF ATHEROSCLEROSIS IN THE CHOLESTEROL-FED RABBIT AND LIPOPROTEIN BINDING TO SMOOTH-MUSCLE CELLS IN CULTURE, Atherosclerosis, 106(1), 1994, pp. 29-41

Authors: FENNESSY PA CAMPBELL JH CAMPBELL GR

Citation: Pa. Fennessy et al., AN ACE-INHIBITOR, PERINDOPRIL, PREVENTS FURTHER DEVELOPMENT OF ATHEROSCLEROSIS, Circulation, 88(4), 1993, pp. 521-521